Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 571

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 2
Chunk 571
---
 906 of the Sarbanes-Oxley Act of 2002.

			97.1

			Incentive Compensation Repayment (Clawback) Policy (included as Exhibit 97.1 to the Company’s Annual Report on Form 10-K filed on December 15, 2023, and incorporated herein by reference).

			101.INS

			Inline XBRL Instance Document

			101.SCH

			Inline XBRL Taxonomy Extension Schema Document

			101.CAL

			Inline XBRL Taxonomy Calculation Linkbase Document

			101.DEF

			Inline XBRL Taxonomy Extension Definition Linkbase Document

			101.LAB

			Inline XBRL Taxonomy Label Linkbase Document

			101.PRE

			Inline XBRL Taxonomy Presentation Linkbase Document

			104

			Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

* All schedules and exhibits to the Share Exchange Agreement have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the Securities and Exchange Commission upon request.

** The information in this exhibit is furnished and deemed not filed with the Securities and Exchange Commission for purposes of section 18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of Edesa Biotech, Inc. under the Securities Act of 1933, as amended, or the Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

@ Management contract or compensatory plan or arrangement.

+ Portions of this exhibit have been omitted pursuant to Rule 601(b)(10)(iv) of Regulation S-K. 

Item 16. FORM 10-K SUMMARY

None.

74

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			EDESA BIOTECH, INC.

			Date: December 12, 2025

			/s/ Pardeep Nijhawan

			Pardeep Nijhawan, MD

			Director, Chief Executive Officer and Corporate Secretary (Principal Executive Officer)

			Date: December 12